Menu

FLUTIPHARM S 250

Salmeterol 25 mcg & Fluticasone Propionate 250 mcg Inhaler

  • Long-acting asthma control with twice-daily dosing
  • Helps reduce wheezing, cough and breathlessness
  • Improves day-to-day breathing comfort
Pack Size 120 Metered Doses
MOQ 10 Case (one case contains 150pcs)
MRP XXXX.XXXX
Mechanism of Action
Anti-inflammatory Action

Reduces airway inflammation by inhibiting release of histamine and inflammatory mediators.

Reduce Bronchial Hyperreactivity

Decreases the heightened sensitivity of the airways to allergens and exercise.

Better Lung Deposition

Optimal aerosol particle size ensures deposition in small airways.

Fewer Systemic Side Effects

High first-pass metabolism limits systemic bioavailability.

Quick Enquiry

Our Team Responds within 24 hours

You May Also Like


BUDIPHARM F 400
BUDIPHARM F 400
Volume Builder

Formoterol Fumarate 6 mcg & Budesonide 400 mcg Inhaler

  • Combines prevention and symptom control in one inhaler
  • Helps reduce asthma symptoms and flare-ups
  • Trusted dual therapy for asthma and COPD

budesonide 200 mcg inhaler
BUDIPHARM 200
Volume Builder

Formoterol Fumarate 6 mcg & Budesonide 200 mcg Inhaler

  • Combines prevention and symptom control in one inhaler
  • Helps reduce asthma symptoms and flare-ups
  • Trusted dual therapy for asthma and COPD

budesonide, glycopyrrolate and formoterol inhaler
BUDIPHARM GF
New Drug

Glycopyrrolate 9 mcg, Formoterol Fumarate 4.8 mcg and Budesonide 160 mcg Inhaler

  • Triple-action therapy for advanced COPD management
  • Helps reduce flare-ups and improve lung function
  • Delivers complete symptom control in one inhaler

tiotropium bromide + formoterol fumarate inhaler
TREVTRO F
Niche Molecule

Tiotropium Bromide 9 mcg and Formoterol Fumarate 6 mcg Inhaler

  • Provides stronger bronchodilation than single therapy
  • Helps improve lung capacity and airflow
  • Designed for long-term COPD control

Budesonide Inhalation IP 200 mcg — PCD Franchise in India


Budecure-200 is a Budesonide MDI inhaler manufactured by Pharmcure Pharmaceuticals Pvt. Ltd., India's leading hyper-focused respiratory pharmaceutical company. It is available for PCD pharma franchise across all districts, cities and states in India including Uttar Pradesh, Maharashtra, Gujarat, Rajasthan, Punjab, Haryana, Madhya Pradesh, Tamil Nadu, Karnataka, Andhra Pradesh, Telangana, Kerala, West Bengal, and all northeastern states.

Distributors looking for a PCD pharma franchise in the respiratory segment can partner with Pharmcure for monopoly distribution rights, exclusive territory, free Pathshala training, and premium promotional inputs including AQI meters and the Doctor's Respiratory Handbook.

Key search terms: Budesonide Inhaler PCD franchise · Budesonide 200 mcg MDI manufacturer India · respiratory PCD pharma company · Budesonide inhaler distributors India · PCD pharma franchise respiratory medicines.

Partner with Pharmacure Today

Start your journey now. Your success in the healthcare industry starts here.

Plot No. : 46, Industrial Area Phase II, Chandigarh, 160002

+2 123 4565 788
+2 123 4565 789

info@pharmcureindia.com

Mon - Sat (10AM - 05PM)
Sunday - Closed

Powered by Joinchat